Riskpilot← Back to searchSign inGet full accessHecoLabs AB
ABActiveOrg 5563947901Torggatan 18 DOther education n.e.c. · NACE 8559Est. 19900 employees
Revenue 2024
SEK 138K
+47% vs 2023
EBITDA margin
-50.7%
+19% vs 2023
Equity ratio
87.2%
Financial strength
Net profit 2024
SEK -85K
-37% vs 2023
| Revenue | SEK 138K | +47% |
| EBITDA | SEK -70K | +19% |
| Net profit | SEK -85K | -37% |
| Total assets | SEK 195K | -28% |
| Equity | SEK 170K | -33% |
| Employees | 0 | — |
Legal name
HecoLabs AB
Org number
5563947901
Legal form
Aktiebolag
NACE code
8559 · Other education n.e.c.
Founded
3 maj 1990
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Aktiebolaget ska bedriva försäljning av kemiska rengörings- produkter för avlopp och andra ytor, mekanisk utrustning för dosering av dessa och därmed förenlig verksamhet.
Address
Torggatan 18 D
Email
elisabeth@heco.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 586 | 372 | 328 | 94 | 138 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 101 | 105 | 42 | −86 | −70 |
| Depreciation & amort. | −25 | −25 | −0 | −25 | −15 |
| EBIT | 76 | 80 | 42 | −111 | −85 |
| Net financials | — | — | — | — | — |
| Profit before tax | 57 | 61 | 32 | −62 | −85 |
| Tax | −12 | −13 | −7 | −0 | −0 |
| Net profit | 45 | 48 | 25 | −62 | −85 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 287 | 355 | 383 | 272 | 195 |
| Equity | 244 | 292 | 317 | 255 | 170 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 23 | 25 | 18 | 17 | 25 |
| Total debt | 23 | 25 | 18 | 17 | 25 |
EBITDA margin
-50.7%
This company
15.8%
Market median
-421% vs market
20202024
Equity ratio
87.2%
This company
38.2%
Market median
+128% vs market
20202024
Return on equity
-50.0%
This company
18.4%
Market median
-372% vs market
20202024
Net profit margin
-61.6%
This company
8.1%
Market median
-860% vs market
20202024
Asset turnover
0.71×
This company
1.12×
Market median
-37% vs market
20202024
Debt / equity
0.15×
This company
0.62×
Market median
+76% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MW Authorized Recipient of Service | Authorized Recipient of Service | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2024 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Board of Directors | 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 | |
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
HECO LABORATORIEUTSTYR AS
HecoLabs AB (this company)Board members of HecoLabs AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Matts Wassdahl | Authorized Recipient of Service | 0 companies |
| Christopher Hellebust | Chairman | 0 companies |
| Lars Magnus Mikkelsen | Board of Directors | 0 companies |
| Sevrin Jan Hellebust | Deputy Board Member | 0 companies |
| Solveig Lilholt | Board of Directors | 0 companies |